IGC Pharma, Inc.

IGC Pharma Inc. (IGC) has reported zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting surface-level stability in this window. However, absence of detected events in a short timeframe does not indicate comprehensive risk assessment—dilution pressure, financing history, and structural vulnerabilities often emerge across longer periods. The full $49 Report extends analysis to 12 months of filings, calculates dilution risk scoring, contextualizes any 8-K activity, and surfaces AI-detected risk signals that a 90-day snapshot cannot capture. The full $49 Report adds dilution trajectory analysis, 12-month financing pattern review, and predictive risk scoring.